首页> 美国卫生研究院文献>OncoTargets and therapy >miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro
【2h】

miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro

机译:miR-132可以在体外通过靶MMP16抑制神经胶质瘤细胞的侵袭和迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gliomas are the most common malignant primary brain tumors, and new clinical biomarkers and therapeutic targets are imminently required. MicroRNAs (miRNAs) are a novel class of small non-coding RNAs (∼22nt) involved in the regulation of various biological processes. Here, by using real-time polymerase chain reaction, miRNA-132 was found to be significantly deregulated in glioma tissues. Based on the prediction of the target genes of miR-132, we hypothesized that there is a significant association between miR-132 and matrix metalloproteinase (MMP) 16 (MT3-MMP), a protein of the MMP family. We showed that the up-expression of miR-132 inhibited cell migration and invasion in the human glioma cell lines A172, SHG44, and U87. Furthermore, the overexpression of miR-132 reduced the expression of MMP16 in A172, SHG44, and U87 cells. Taken together, our study suggested that miR-132 affects glioma cell migration and invasion by MMP16 and implicates miR-132 as a metastasis-inhibiting miRNA in gliomas.
机译:神经胶质瘤是最常见的恶性原发性脑肿瘤,迫切需要新的临床生物标志物和治疗靶标。微小RNA(miRNA)是一类新颖的小型非编码RNA(〜22nt),参与各种生物过程的调控。在这里,通过使用实时聚合酶链反应,发现miRNA-132在神经胶质瘤组织中显着失调。基于对miR-132靶基因的预测,我们假设miR-132与基质金属蛋白酶(MMP)16(MT3-MMP)(一种MMP家族蛋白)之间存在显着关联。我们显示,miR-132的表达上调抑制了人类胶质瘤细胞系A172,SHG44和U87中的细胞迁移和侵袭。此外,miR-132的过表达降低了A172,SHG44和U87细胞中MMP16的表达。综上所述,我们的研究表明miR-132通过MMP16影响神经胶质瘤细胞的迁移和侵袭,并暗示miR-132作为胶质瘤中的一种转移抑制性miRNA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号